This topic contains a solution. Click here to go to the answer

Author Question: The client is visiting the healthcare provider's office for a head-to-toe assessment. During the ... (Read 43 times)

123654777

  • Hero Member
  • *****
  • Posts: 585
The client is visiting the healthcare provider's office for a head-to-toe assessment. During the nurse's assessment of the client's skin, the nurse notes that the client is pale. Which assessment data may be related to the client's color?
 
  Select all that apply.
  1. Client's blood pressure is 96/62.
  2. The client states, I just smoked a cigarette before I came in the office.
  3. The client's oxygen saturation level is 86 on room air.
  4. The client states, I have been diagnosed with osteoporosis.
  5. The client states, It is snowing again outside with a wind chill factor of -11 degrees Fahrenheit.

Question 2

The nurse is conducting a focused interview on the client's integumentary system and prepares to obtain data related to risk factors for the development of integumentary disorders.
 
  Which question by the nurse would be unexpected based on the specific data the nurse is attempting to gain during the interview?
  Select all that apply.
  1. How much time do you spend outdoors?
  2. How do you care for your skin?
  3. Do you have any tattoos or body piercings?
  4. Have you noticed any drainage from your skin?
  5. Do you take any medications on a regular basis?



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
Marked as best answer by a Subject Expert

abro1885

  • Sr. Member
  • ****
  • Posts: 337
Answer to Question 1

Correct Answer: 1, 2, 3, 5
Pallor may be seen in the client with hypotension. It can be produced by the sympathetic nervous stimulation that results in vasoconstriction due to smoking cigarettes. The client with a decreased oxygen saturation level may exhibit pallor. A cold environment can produce vasoconstriction and pallor. It is not normally associated with osteoporosis.

Answer to Question 2

Correct Answer: 1, 2, 3, 5

The nurse can ask the client about the amount of time that the client spends outside. Spending time outside in the sunshine is a risk factor for the development of skin disorders, such as squamous cell carcinoma. The nurse can ask the client about the way that the client cares for the skin. There may be something that the client is doing while caring for the skin that is a risk factor for the development of an integumentary disorder. Tattoos and body piercings can increase the client's risk for developing an integumentary disorder. Certain medications, if taken on a regular basis, can increase the client's risk for developing skin disorders. When the nurse asks the client about the presence of drainage from the skin, this question is directed at determining the presence of a clinical manifestation of an integumentary disorder. This question is not necessarily directed at gaining information about risk factors.




123654777

  • Member
  • Posts: 585
Reply 2 on: Jun 25, 2018
Gracias!


ASDFGJLO

  • Member
  • Posts: 335
Reply 3 on: Yesterday
Excellent

 

Did you know?

Though newer “smart” infusion pumps are increasingly becoming more sophisticated, they cannot prevent all programming and administration errors. Health care professionals that use smart infusion pumps must still practice the rights of medication administration and have other professionals double-check all high-risk infusions.

Did you know?

Children of people with alcoholism are more inclined to drink alcohol or use hard drugs. In fact, they are 400 times more likely to use hard drugs than those who do not have a family history of alcohol addiction.

Did you know?

Cytomegalovirus affects nearly the same amount of newborns every year as Down syndrome.

Did you know?

In ancient Rome, many of the richer people in the population had lead-induced gout. The reason for this is unclear. Lead poisoning has also been linked to madness.

Did you know?

Bisphosphonates were first developed in the nineteenth century. They were first investigated for use in disorders of bone metabolism in the 1960s. They are now used clinically for the treatment of osteoporosis, Paget's disease, bone metastasis, multiple myeloma, and other conditions that feature bone fragility.

For a complete list of videos, visit our video library